O	0	10	Randomized
O	11	16	Trial
O	17	26	Comparing
B-intervention	27	36	Telephone
O	37	43	Versus
B-intervention	44	46	In
I-intervention	46	47	-
I-intervention	47	53	Person
I-intervention	54	60	Weight
I-intervention	61	65	Loss
I-intervention	66	76	Counseling
O	77	79	on
O	80	84	Body
O	85	96	Composition
O	97	100	and
O	101	112	Circulating
O	113	123	Biomarkers
O	124	126	in
O	127	132	Women
O	133	140	Treated
O	141	144	for
O	145	151	Breast
O	152	158	Cancer
O	158	159	:
O	160	163	The
O	164	173	Lifestyle
O	173	174	,
O	175	183	Exercise
O	183	184	,
O	185	188	and
O	189	198	Nutrition
O	199	200	(
O	200	204	LEAN
O	204	205	)
O	206	211	Study
O	211	212	.

O	213	220	Obesity
O	221	223	is
O	224	234	associated
O	235	239	with
O	240	241	a
O	242	248	higher
O	249	253	risk
O	254	256	of
O	257	263	breast
O	264	270	cancer
O	271	280	mortality
O	280	281	.

O	282	285	The
O	286	290	gold
O	291	299	standard
O	300	308	approach
O	309	311	to
O	312	318	weight
O	319	323	loss
O	324	326	is
O	327	329	in
O	329	330	-
O	330	336	person
O	337	347	counseling
O	347	348	,
O	349	352	but
O	353	362	telephone
O	363	373	counseling
O	374	377	may
O	378	380	be
O	381	385	more
O	386	394	feasible
O	394	395	.

O	396	398	We
O	399	407	examined
O	408	411	the
O	412	418	effect
O	419	421	of
O	422	424	in
O	424	425	-
O	425	431	person
O	432	438	versus
O	439	448	telephone
O	449	455	weight
O	456	460	loss
O	461	471	counseling
O	472	478	versus
B-control	479	484	usual
I-control	485	489	care
O	490	492	on
O	493	494	6
O	494	495	-
O	495	500	month
O	501	508	changes
O	509	511	in
O	512	516	body
O	517	528	composition
O	528	529	,
O	530	538	physical
O	539	547	activity
O	547	548	,
O	549	553	diet
O	553	554	,
O	555	558	and
O	559	564	serum
O	565	575	biomarkers
O	575	576	.

B-total-participants	577	580	One
I-total-participants	581	588	hundred
B-eligibility	589	595	breast
I-eligibility	596	602	cancer
I-eligibility	603	612	survivors
I-eligibility	613	617	with
I-eligibility	618	619	a
I-eligibility	620	624	body
I-eligibility	625	629	mass
I-eligibility	630	635	index
I-eligibility	636	637	≥
I-eligibility	638	640	25
I-eligibility	641	643	kg
I-eligibility	643	644	/
I-eligibility	644	645	m
I-eligibility	645	646	(
I-eligibility	646	647	2
I-eligibility	647	648	)
O	649	653	were
O	654	662	randomly
O	663	671	assigned
O	672	674	to
O	675	677	in
O	677	678	-
O	678	684	person
O	685	695	counseling
O	696	697	(
O	697	698	n
O	699	700	=
B-intervention-participants	701	703	33
O	703	704	)
O	704	705	,
O	706	715	telephone
O	716	726	counseling
O	727	728	(
O	728	729	n
O	730	731	=
B-intervention-participants	732	734	34
O	734	735	)
O	735	736	,
O	737	739	or
B-control	740	745	usual
I-control	746	750	care
I-control	751	752	(
I-control	752	754	UC
I-control	754	755	)
O	756	757	(
O	757	758	n
O	759	760	=
B-control-participants	761	763	33
O	763	764	)
O	764	765	.

O	766	768	In
O	768	769	-
O	769	775	person
O	776	779	and
O	780	789	telephone
O	790	800	counseling
O	801	809	included
O	810	812	11
O	813	815	30
O	815	816	-
O	816	822	minute
O	823	833	counseling
O	834	842	sessions
O	843	847	over
O	848	849	6
O	850	856	months
O	856	857	.

O	858	863	These
O	864	871	focused
O	872	874	on
O	875	883	reducing
O	884	891	caloric
O	892	898	intake
O	898	899	,
O	900	910	increasing
O	911	919	physical
O	920	928	activity
O	928	929	,
O	930	933	and
O	934	944	behavioral
O	945	952	therapy
O	952	953	.

O	954	958	Body
O	959	970	composition
O	970	971	,
O	972	980	physical
O	981	989	activity
O	989	990	,
O	991	995	diet
O	995	996	,
O	997	1000	and
O	1001	1006	serum
O	1007	1017	biomarkers
O	1018	1022	were
O	1023	1031	measured
O	1032	1034	at
O	1035	1043	baseline
O	1044	1047	and
O	1048	1049	6
O	1050	1056	months
O	1056	1057	.

O	1058	1061	The
O	1062	1066	mean
O	1067	1070	age
O	1071	1073	of
O	1074	1086	participants
O	1087	1090	was
B-age	1091	1093	59
I-age	1094	1095	±
I-age	1096	1097	7
I-age	1097	1098	.
I-age	1098	1099	5
I-age	1100	1105	years
O	1106	1109	old
O	1109	1110	,
O	1111	1115	with
O	1116	1117	a
O	1118	1122	mean
O	1123	1126	BMI
O	1127	1129	of
O	1130	1132	33
O	1132	1133	.
O	1133	1134	1
O	1135	1136	±
O	1137	1138	6
O	1138	1139	.
O	1139	1140	6
O	1141	1143	kg
O	1143	1144	/
O	1144	1145	m
O	1145	1146	(
O	1146	1147	2
O	1147	1148	)
O	1148	1149	,
O	1150	1153	and
O	1154	1157	the
O	1158	1162	mean
O	1163	1167	time
O	1168	1172	from
O	1173	1182	diagnosis
O	1183	1186	was
O	1187	1188	2
O	1188	1189	.
O	1189	1190	9
O	1191	1192	±
O	1193	1194	2
O	1194	1195	.
O	1195	1196	1
O	1197	1202	years
O	1202	1203	.

O	1204	1209	Fifty
O	1209	1210	-
O	1210	1213	one
O	1214	1221	percent
O	1222	1224	of
O	1225	1228	the
O	1229	1241	participants
O	1242	1245	had
O	1246	1251	stage
O	1252	1253	I
O	1254	1260	breast
O	1261	1267	cancer
O	1267	1268	.

B-outcome	1269	1276	Average
I-outcome	1277	1278	6
I-outcome	1278	1279	-
I-outcome	1279	1284	month
I-outcome	1285	1291	weight
I-outcome	1292	1296	loss
O	1297	1300	was
B-iv-bin-percent	1301	1302	6
I-iv-bin-percent	1302	1303	.
I-iv-bin-percent	1303	1304	4
I-iv-bin-percent	1304	1305	%
O	1305	1306	,
B-iv-bin-percent	1307	1308	5
I-iv-bin-percent	1308	1309	.
I-iv-bin-percent	1309	1310	4
I-iv-bin-percent	1310	1311	%
O	1311	1312	,
O	1313	1316	and
B-cv-bin-percent	1317	1318	2
I-cv-bin-percent	1318	1319	.
I-cv-bin-percent	1319	1320	0
I-cv-bin-percent	1320	1321	%
O	1322	1325	for
O	1326	1328	in
O	1328	1329	-
O	1329	1335	person
O	1335	1336	,
O	1337	1346	telephone
O	1346	1347	,
O	1348	1351	and
O	1352	1354	UC
O	1355	1361	groups
O	1361	1362	,
O	1363	1375	respectively
O	1376	1377	(
O	1377	1378	P
O	1379	1380	=
O	1381	1382	.
O	1382	1385	004
O	1385	1386	,
O	1387	1388	P
O	1389	1390	=
O	1391	1392	.
O	1392	1395	009
O	1395	1396	,
O	1397	1400	and
O	1401	1402	P
O	1403	1404	=
O	1405	1406	.
O	1406	1408	46
O	1409	1418	comparing
O	1419	1421	in
O	1421	1422	-
O	1422	1428	person
O	1429	1433	with
O	1434	1436	UC
O	1436	1437	,
O	1438	1447	telephone
O	1448	1452	with
O	1453	1455	UC
O	1455	1456	,
O	1457	1460	and
O	1461	1463	in
O	1463	1464	-
O	1464	1470	person
O	1471	1475	with
O	1476	1485	telephone
O	1485	1486	,
O	1487	1499	respectively
O	1499	1500	)
O	1500	1501	.

O	1502	1503	A
O	1504	1515	significant
B-iv-bin-percent	1516	1518	30
I-iv-bin-percent	1518	1519	%
B-outcome	1520	1528	decrease
I-outcome	1529	1531	in
I-outcome	1532	1533	C
I-outcome	1533	1534	-
I-outcome	1534	1542	reactive
I-outcome	1543	1550	protein
I-outcome	1551	1557	levels
O	1558	1561	was
O	1562	1570	observed
O	1571	1576	among
O	1577	1582	women
O	1583	1591	randomly
O	1592	1600	assigned
O	1601	1603	to
O	1604	1607	the
O	1608	1616	combined
O	1617	1623	weight
O	1624	1628	loss
O	1629	1641	intervention
O	1642	1648	groups
O	1649	1657	compared
O	1658	1662	with
O	1663	1664	a
B-cv-bin-percent	1665	1666	1
I-cv-bin-percent	1666	1667	%
O	1668	1676	decrease
O	1677	1682	among
O	1683	1688	women
O	1689	1697	randomly
O	1698	1706	assigned
O	1707	1709	to
O	1710	1712	UC
O	1713	1714	(
O	1714	1715	P
O	1716	1717	=
O	1718	1719	.
O	1719	1721	05
O	1721	1722	)
O	1722	1723	.

O	1724	1728	Both
O	1729	1731	in
O	1731	1732	-
O	1732	1738	person
O	1739	1742	and
O	1743	1752	telephone
O	1753	1763	counseling
O	1764	1768	were
O	1769	1778	effective
O	1779	1785	weight
O	1786	1790	loss
O	1791	1801	strategies
O	1801	1802	,
O	1803	1807	with
O	1808	1817	favorable
O	1818	1825	effects
O	1826	1828	on
O	1829	1830	C
O	1830	1831	-
O	1831	1839	reactive
O	1840	1847	protein
O	1848	1854	levels
O	1854	1855	.

O	1856	1859	Our
O	1860	1868	findings
O	1869	1872	may
O	1873	1877	help
O	1878	1883	guide
O	1884	1887	the
O	1888	1901	incorporation
O	1902	1904	of
O	1905	1911	weight
O	1912	1916	loss
O	1917	1927	counseling
O	1928	1932	into
O	1933	1939	breast
O	1940	1946	cancer
O	1947	1956	treatment
O	1957	1960	and
O	1961	1965	care
O	1965	1966	.
